IDEXX Laboratories (NASDAQ:IDXX) Knows How To Allocate Capital
23 Most Profitable Stocks of the Last 12 Months
In this article, we discuss the 23 most profitable stocks of the last 12 months.
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2024 Earnings Call Transcript
IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
IDEXX Labs Price Target Cut to $570.00/Share From $655.00 by Barclays
IDEXX Labs Is Maintained at Overweight by Barclays
IDEXX Labs Is Maintained at Overweight by Barclays
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
Barclays: The IDEXX Laboratories (IDXX.US) rating was maintained, and the target price was adjusted from $655.00 to $570.00.
Barclays Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $570
Barclays analyst Balaji Prasad maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $655 to $570.
IDEXX Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 20.41% Barclays $655 → $570 Maintains Overweight 02/06/2024 33.09% JP Morgan $600 → $630 Mainta
Redburn Atlantic Adjusts Price Target on IDEXX Laboratories to $500 From $460
IDEXX Laboratories (IDXX) has an average outperform rating and price target range of $400 to $653, according to analysts polled by Capital IQ. Price: 470.71, Change: +2.67, Percent Change: +0.57
Zoetis Stock Climbs on Earnings Beat, but Worries Linger Over Key Medicine -- Barrons.com
By Josh Nathan-Kazis Zoetis reported financial results for the first quarter that were slightly better than Wall Street expected as worries about its new pain medicines for dogs and cats continue to
IDEXX Laboratories Inc (IDXX) (Q1 2024) Earnings Call Transcript Highlights: Key Financial ...
Aging Pet Population Is 'Solid Longer-Term Tailwind' For IDEXX Labs: Analyst
Wednesday, IDEXX Laboratories Inc (NASDAQ:IDXX) reported first-quarter adjusted EPS of $2.81, up 10% Y/Y, beating the consensus of $2.67.The company reported sales of $964 million, an increase of 7% a
Earnings Call Summary | IDEXX Laboratories Inc(IDXX.US) Q1 2024 Earnings Conference
The following is a summary of the IDEXX Laboratories, Inc. (IDXX) Q1 2024 Earnings Call Transcript:Financial Performance:IDEXX reported a 7% organic Q1 revenue growth, driven by a similar increase in
Research Alert: CFRA Keeps Hold Opinion On Shares Of Idexx Laboratories, Inc.
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We lower our target price to $507 from
IDEXX Labs Cuts 2024 Revenue Forecast on Lagging Vet Visits, Strong Dollar
IDEXX Laboratories Inc (IDXX) Q1 Earnings: Exceeds Revenue Estimates, EPS Surpasses Expectations
Idexx 1Q Net Up; Lowers Guidance for The Year
By Rob Curran Idexx Laboratories posted first-quarter net income growth but cut its projection for 2024 revenue growth amid signs that the pet-care boom that began during the pandemic may be easing.
Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q1 Revenue $964.1M, Vs. Street Est of $965.8M
06:38 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (IDXX) IDEXX LABORATORIES Posts Q1 Revenue $964.1M, vs. Street Est of $965.8M
IDEXX Labs Sees 2024 EPS $10.82-EPS $11.20 >IDXX
IDEXX Labs Sees 2024 EPS $10.82-EPS $11.20 >IDXX
IDEXX Laboratories Reports Mixed Q1 Results; Updates FY24 Outlook
No Data